Clinical trial

Standard Optimization of Stem Cells in Parkinson's Disease and Atypical Parkinsonism

NCT06858254

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-04-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2025-04-01Date precision: day

Registry last updated2025-03-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Atypical Parkinsonismunresolved

Parkinson Disease (PD)unresolved

Interventions

Autologous mesenchymal stem cellsBIOLOGICAL

Sponsors & collaborators

Apeiron Research Centerlead sponsor

University of Colorado, Bouldercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06858254 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.